There is a trend for pharmaceutical companies to contract third parties to conduct the clinical trials that are needed to test their drugs. This trend is referred to as , and the companies that carry out the work are called contract research organisations. In addition, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low- and middle-income countries. This trend is called . The combination of outsourcing and offshoring poses serious risks for the ethical treatment of participants in clinical trials.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735062 | PMC |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!